Richard F. Maradie
Directeur/Membre du Conseil chez SYMBOLLON PHARMACEUTICALS INC.
Profil
Richard F.
Maradie is an Independent Director at Symbollon Pharmaceuticals, Inc. He previously served as the President, Chief Executive Officer & Director at Novavax, Inc. from 1997 to 1998.
Prior to that, he was the President, Chief Operating Officer & Director at VIMRx Pharmaceuticals, Inc. from 1988 to 1991.
He also held the position of Senior Vice President-Commercial Development at Oakwood Laboratories LLC from 1998 to 2000.
Postes actifs de Richard F. Maradie
Sociétés | Poste | Début |
---|---|---|
SYMBOLLON PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/01/1998 |
Anciens postes connus de Richard F. Maradie
Sociétés | Poste | Fin |
---|---|---|
Oakwood Laboratories LLC
Oakwood Laboratories LLC Pharmaceuticals: MajorHealth Technology Oakwood Laboratories LLC operates as a technology-based specialty pharmaceutical company. The firm focuses on hard-to-develop generic and quasi-generic, sustained-release, and small molecule injectables. It develops and owns a patented microsphere-based drug delivery platform under Chroniject trademark. The company was founded by Edward C. Smith and Mark T. Smith in 1997 and is headquartered in Oakwood Village, OH. | Corporate Officer/Principal | 01/09/2000 |
NOVAVAX, INC. | President | 01/08/1998 |
VIMRx Pharmaceuticals, Inc. | President | 01/01/1991 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Symbollon Pharmaceuticals, Inc.
Symbollon Pharmaceuticals, Inc. BiotechnologyHealth Technology Symbollon Pharmaceuticals, Inc. develops and sells pharmaceutical products based on iodine technology. The company was founded by Jack H. Kessler in July 1986 and is headquartered in Medfield, MA. | Health Technology |
VIMRx Pharmaceuticals, Inc. | Health Technology |
Oakwood Laboratories LLC
Oakwood Laboratories LLC Pharmaceuticals: MajorHealth Technology Oakwood Laboratories LLC operates as a technology-based specialty pharmaceutical company. The firm focuses on hard-to-develop generic and quasi-generic, sustained-release, and small molecule injectables. It develops and owns a patented microsphere-based drug delivery platform under Chroniject trademark. The company was founded by Edward C. Smith and Mark T. Smith in 1997 and is headquartered in Oakwood Village, OH. | Health Technology |